Intrinsic Value of S&P & Nasdaq Contact Us

Dynavax Technologies Corporation DVAX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.00
+100%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Dynavax Technologies Corporation (DVAX) trades at a trailing P/E of 77.5, forward P/E of 31.6. Trailing earnings yield is 1.29%, forward earnings yield 3.17%. PEG 0.22 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (62/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.22); analyst target implies upside (+100%).
  • Forward P/E 31.6 (down from trailing 77.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.29% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.17% as earnings recover.
  • Analyst consensus target $31.00 (+100% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
71/100
SG Score
View full scorecard →
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
83/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — DVAX

Valuation Multiples
P/E (TTM)77.5
Forward P/E31.6
PEG Ratio0.22
Forward PEG0.22
P/B Ratio0.00
P/S Ratio7.45
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.20
Forward EPS (Est.)$0.49
Book Value / Share$0.00
Revenue / Share$2.08
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.29%
Forward Earnings Yield3.17%
Dividend Yield0.00%
Analyst Target$31.00 (+100%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-3.25 $4.05M $-106.79M -2636.9%
2016 $-2.92 $11.04M $-112.44M -1018.2%
2017 $-1.81 $327K $-95.15M -29099.1%
2018 $-2.55 $8.2M $-158.9M -1938.3%
2019 $-2.10 $35.22M $-151.4M -429.9%
2020 $-0.91 $46.55M $-91.78M -197.2%
2021 $0.54 $439.44M $76.71M 17.5%
2022 $1.97 $722.68M $293.16M 40.6%
2023 $-0.05 $232.28M $-6.39M -2.8%
2024 $0.20 $277.25M $27.31M 9.9%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message